Global Anthelmintic Drugs Market Growth 2023-2029

Global Anthelmintic Drugs Market Growth 2023-2029

Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).

LPI (LP Information)' newest research report, the “Anthelmintic Drugs Industry Forecast” looks at past sales and reviews total world Anthelmintic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anthelmintic Drugs sales for 2023 through 2029. With Anthelmintic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anthelmintic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anthelmintic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anthelmintic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anthelmintic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anthelmintic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anthelmintic Drugs.

The global Anthelmintic Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Anthelmintic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Anthelmintic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Anthelmintic Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Anthelmintic Drugs players cover Novartis, Pfizer, Bayer, Cipla, Sun Pharmaceutical Industries, Mankind Pharma, Johnson & Johnson and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Anthelmintic Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Oral Drugs
Injectables

Segmentation by application
For Human
For Animal

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anthelmintic Drugs market?

What factors are driving Anthelmintic Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anthelmintic Drugs market opportunities vary by end market size?

How does Anthelmintic Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.